SERTRALINE 50mg. IP

An antidepressant drug that is indicated in the treatment of neurological diseases such as depression, anxiety, obsessive-compulsive disorder, and posttraumatic stress disorder. A potent and selective inhibitor of serotonin reuptake exerts both antidepressant and antianxiety effects. (G MacQueen, 2001) A promising therapeutic and prophylactic alternative in the pharmacologic management of depression. (Shelton, 1994) Reduces anxiety symptoms such as nervousness, irritability, and restlessness in depressed individuals. (Mahase, 2019) Offers advantages over selective serotonin reuptake inhibitors namely, paroxetine, fluoxetine, and fluvoxamine in elderly patients with major depressive disorder. (Richard B R Muijsers G. L., 2002) The first‐line agent for the treatment of several psychiatric disorders. (Glenda MacQueen, 2001) A well-tolerated treatment for generalized anxiety disorder in both men and women. (Meir Steiner, 2005) An efficacious candidate for the treatment of depression and obsessive-compulsive disorder. (Guthrie, 1991) Produces greater improvements in the quality of a patient’s life and is better tolerated than amitriptyline therapy in patients with major depression. (R B Lydiard, 1997) Shows significantly greater tolerability and compliance during long-term treatment than imipramine in patients with panic disorder and major depressive disorder. (Ulla Lepola, 2003) Demonstrates a significantly greater reduction in depression severity compared to nortriptyline. (S I Finkel, 1999)